Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004224008 | SCV003729386 | uncertain significance | not specified | 2022-12-28 | criteria provided, single submitter | clinical testing | The c.1349T>C (p.L450P) alteration is located in exon 3 (coding exon 3) of the KBTBD12 gene. This alteration results from a T to C substitution at nucleotide position 1349, causing the leucine (L) at amino acid position 450 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |